====== COVID-19 Vaccine Associated Axillary Adenopathy ====== See also: [[covid-19_vaccines:adverse_events:lymphadenopathy:|CoVid-19 Vaccine Associated Lymphadenopathy]] ===== Peer-Reviewed Scientific papers regarding COVID-19 Vaccine Associated Axillary Adenopathy ===== [[https://www.sciencedirect.com/science/article/pii/S1930043321002612|COVID-19 vaccine-induced axillary and pectoral lymphadenopathy in PET ]] [[https://pubmed.ncbi.nlm.nih.gov/34735411/|Evolution of bilateral hypermetabolic axillary hypermetabolic lymphadenopathy on FDG PET/CT after 2-dose COVID-19 vaccination]] [[https://pubmed.ncbi.nlm.nih.gov/34836672/|COVID-19 vaccine-related axillary lymphadenopathy in breast cancer patients: case series with literature review.]] [[https://pubmed.ncbi.nlm.nih.gov/34906409/|Subclinical axillary lymphadenopathy associated with COVID-19 vaccination on screening mammography]] [[https://pubmed.ncbi.nlm.nih.gov/33624520/|Axillary adenopathy associated with COVID-19 vaccination: imaging findings and follow-up recommendations in 23 women]] [[https://pubmed.ncbi.nlm.nih.gov/34298342/|Unilateral axillary adenopathy in the setting of COVID-19 vaccination: follow-up]] [[https://pubmed.ncbi.nlm.nih.gov/34719892/|COVID-19 vaccine-related axillary and cervical lymphadenopathy in patients with current or previous breast cancer and other malignancies: cross-sectional imaging findings on MRI, CT and PET-CT]] [[https://pubmed.ncbi.nlm.nih.gov/34292295/|Incidence of axillary adenopathy on breast imaging after vaccination with COVID-19.]] [[https://pubmed.ncbi.nlm.nih.gov/34325221/|Unilateral axillary lymphadenopathy related to COVID-19 vaccine: pattern on screening breast MRI allowing benign evaluation]] [[https://pubmed.ncbi.nlm.nih.gov/34825530/|Axillary lymphadenopathy in patients with recent Covid-19 vaccination: a new diagnostic dilemma.]] [[https://pubmed.ncbi.nlm.nih.gov/34655312/|COVID-19 vaccine-induced unilateral axillary adenopathy: follow-up evaluation in the USA.]] [[https://pubmed.ncbi.nlm.nih.gov/33624520/|Axillary adenopathy associated with COVID-19 vaccination: imaging findings and follow-up recommendations in 23 women]] [[https://pubmed.ncbi.nlm.nih.gov/34298342/|Unilateral axillary adenopathy in the setting of COVID-19 vaccination: follow-up]] [[https://pubmed.ncbi.nlm.nih.gov/34292295/|Incidence of axillary adenopathy on breast imaging after vaccination with COVID-19.]] [[https://pubmed.ncbi.nlm.nih.gov/34325221/|Unilateral axillary lymphadenopathy related to COVID-19 vaccine: pattern on screening breast MRI allowing benign evaluation]] [[https://pubmed.ncbi.nlm.nih.gov/34825530/|Axillary lymphadenopathy in patients with recent Covid-19 vaccination: a new diagnostic dilemma.]] [[https://pubmed.ncbi.nlm.nih.gov/34655312/|COVID-19 vaccine-induced unilateral axillary adenopathy: follow-up evaluation in the USA.]] [[https://pubmed.ncbi.nlm.nih.gov/33625299/|Adenopathy after COVID-19 vaccination]]